S&P 500 Futures
(-0.63%) 5 075.50 points
Dow Jones Futures
(-0.55%) 38 467 points
Nasdaq Futures
(-0.96%) 17 494 points
Oil
(0.18%) $82.96
Gas
(0.42%) $1.660
Gold
(0.15%) $2 341.90
Silver
(0.44%) $27.47
Platinum
(-0.31%) $913.00
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.33%) $10.95
USD/GBP
(-0.38%) $0.799
USD/RUB
(-0.25%) $92.09

Realtime updates for Lyra Therapeutics Inc [LYRA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
50.00%
return 3.06%
SELL
50.00%
return 5.37%
Last Updated24 Apr 2024 @ 16:00

0.38% $ 5.23

BUY 101724 min ago

@ $4.78

Issued: 14 Feb 2024 @ 15:33


Return: 9.41%


Previous signal: Feb 9 - 14:49


Previous signal: Sell


Return: 2.36 %

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):
Profile picture for Lyra Therapeutics Inc

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases...

Stats
Today's Volume 120 722
Average Volume 345 967
Market Cap 312.46M
EPS $0 ( 2024-04-03 )
Next earnings date ( $-0.260 ) 2024-05-10
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.15
ATR14 $0.0150 (0.29%)
Insider Trading
Date Person Action Amount type
2024-03-18 Waksal Harlan Buy 275 000 Common Stock
2024-03-18 Palasis Maria Buy 500 000 Stock Option
2024-01-30 Bishop John E Buy 200 000 Stock Options
2024-01-30 Nieman Richard Buy 200 000 Stock Options
2024-01-30 Cavalier Jason Buy 200 000 Stock Options
INSIDER POWER
100.00
Last 92 transactions
Buy: 35 062 945 | Sell: 0

Volume Correlation

Long: 0.00 (neutral)
Short: -0.77 (moderate negative)
Signal:(48.538) Neutral

Lyra Therapeutics Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lyra Therapeutics Inc Correlation - Currency/Commodity

The country flag 0.50
( weak )
The country flag 0.53
( weak )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )
The country flag -0.28
( neutral )
The country flag 0.37
( neutral )

Lyra Therapeutics Inc Financials

Annual 2023
Revenue: $1.56M
Gross Profit: $1.28M (82.16 %)
EPS: $-1.260
Q4 2023
Revenue: $146 000
Gross Profit: $61 000.00 (41.78 %)
EPS: $-0.260
Q3 2023
Revenue: $544 000
Gross Profit: $-11.82M (-2 173.53 %)
EPS: $-0.270
Q2 2023
Revenue: $458 000
Gross Profit: $-10.34M (-2 257.86 %)
EPS: $-0.360

Financial Reports:

No articles found.

Lyra Therapeutics Inc

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators